Preliminary study: drug may be safe in those with mild cognitive impairment, mild dementia - EurekAlert
A small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Alzheimer’s disease suggests it is safe and may be associated with improvements in executive function, thinking and memory …
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, THURSDAY, MARCH 31, 2022
MINNEAPOLIS – A small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia … [+4086 chars]
Read More
Other Stories in Health
- 3 nutrients that work best to improve memory and intelligence
- Can Combined Renal Function Markers & Blood Lipid Levels Predict PE?
- Exclusive: World Cancer Day 2025 - 'India Will See Rise Of 12% To 18% In Cancer Cases', Why Are People More at Risk In Recent Times
- How My Ex and I Created a Beautiful Friendship
- Weekly Horoscope For January 27-February 2, From The AstroTwins
- EMCrit 393 – CV-EMCrit – Inotrope Basics Part 1
- How to ace the perfect tri-colour makeup on Republic Day 2025
- Immune environment found to influence success of leukemia immunotherapy
- University Hospitals introduces endoscopic spine surgery for back pain patients with herniated discs